Survival benefit of deceased donor kidney transplantation versus continued dialysis
A more visual summary of the target trial emulation and relevant context (just 7 images to look at!). Infographics by Anca Stefan and Cristina Popa
Day 3 : yet another IgA trial, and we are back with some flozin news: in ADPKD, their effect on hemoglobin, and on BP (with finerenone)
Day 2 was less exciting: we cover 1 IgA trial (Ravulizumab) along with another calcimimetic, and a pentoxifylline meta-analysis.
Day of Kidney Week 2026. The NephJC crew discusses 6 studies, including some blockbustr IgA news.
This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.
A more visual summary of the target trial emulation and relevant context (just 7 images to look at!). Infographics by Anca Stefan and Cristina Popa
This week, we will discuss whether decreased donor transplantation improves mortality in all patients. In this target trial emulation standard donor, extended donor, donation after brain death and donation after cardiac death outcomes are compared across age groups with different co-morbid conditions.
Should we continue metformin in eGFR under 30 ml/min? The visual abstract by Cristina Popa summarizes the conclusions from the Scottish cohort using target trial methodology.
Third instalment of our NephJC summary tweetorials - catch it at the link to learn more about the trade-offs in timing when best to start dialysis in progressive CKD.
Welcome to #TenTweetNephJC
— Nephrology Jrnl Club (@NephJC) February 16, 2022
✳️ 10 tweets to catch-up on the most recent #NephJC ✳️
This week - when is the ideal time to start dialysis in progressive chronic kidney disease?
Later starts lower the burden on patients & use of healthcare resources, but what’s the trade-off? pic.twitter.com/CG2YavjzEQ
Created in a time crunch, the visual abstract for this week’s study from Elena Cervantes: